v3.25.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2025
Stockholders Equity  
Stockholders' Equity

12. Stockholders’ Equity

Preferred stock

The Company has 10,000,000 shares of preferred stock authorized, of which no shares were issued and outstanding as of June 30, 2025 and December 31, 2024.

Common stock

The Company has 500,000,000 shares of common stock authorized, of which 83,905,417 and 72,068,059 shares were issued and outstanding as of June 30, 2025 and December 31, 2024, respectively. Common stockholders are entitled to one vote for each share of outstanding common stock held at all meetings of stockholders and written actions in lieu of meetings. Common stockholders are entitled to receive dividends for each share of outstanding common stock, if and when declared by the Board. No dividends have been declared or paid by the Company through June 30, 2025.

In June 2025, the Company issued 7,518,797 shares of common stock at $6.65 per share resulting in net proceeds of approximately $46.8 million after deducting underwriting discounts, commissions and offering expenses.

In July 2025, the Company issued 7,500,000 shares of common stock at a public offering price of $8.00 per share resulting in net proceeds of approximately $56.4 million after deducting underwriting discounts, commissions and offering expenses.

The following shares were issued to consultants and vendors for the three months ended June 30, 2025:

 

Description

 

Origination Date

 

Shares

 

 

Fair Value

 

 

Settlement Date

 

Fair Value at Settlement

 

 

Change in Fair Value

 

Settlement of liability with consultants

 

January 2025

 

 

50,000

 

 

$

247,000

 

 

April 2025

 

$

326,500

 

 

$

79,500

 

Issuance of common stock to consultant

 

April 2025

 

 

50,000

 

 

 

326,500

 

 

April 2025

 

 

326,500

 

 

 

 

Issuance of restricted common stock to consultants

 

April 2025

 

 

180,000

 

 

 

1,175,400

 

 

April 2025

 

 

1,175,400

 

 

 

 

 

 

 

 

280,000

 

 

$

1,748,900

 

 

 

 

$

1,828,400

 

 

$

79,500

 

The following shares were issued to consultants and vendors for the three months ended June 30, 2024:

 

Description

 

Origination Date

 

Shares

 

 

Fair Value

 

 

Settlement Date

 

Fair Value at Settlement

 

 

Change in Fair Value

 

Settlement of liability with consultants

 

January 2024

 

 

100,000

 

 

$

195,000

 

 

September 2024

 

$

219,500

 

 

$

(24,500

)

Settlement of liability with consultants

 

April 2024

 

 

60,000

 

 

 

240,600

 

 

June 2024

 

 

183,600

 

 

$

57,000

 

Issuance of common stock to consultant

 

June 2024

 

 

60,000

 

 

 

183,600

 

 

June 2024

 

 

183,600

 

 

$

 

 

 

 

 

220,000

 

 

$

619,200

 

 

 

 

$

586,700

 

 

$

32,500

 

During the three months ended June 30, 2025 and 2024, the Company issued shares of common stock to consultants and vendors to settle share liabilities. The fair value of these shares is recorded to share liability in the consolidated balance sheet and the change in

fair value upon settlement of the share liability is recorded to change in fair value of share liability in the consolidated statements of operations and comprehensive loss.

Activity of the share liabilities for the six months ended June 30, 2025 is as follows:

 

 

Share Liability as of December 31,
2024

 

 

New Share
Liabilities in
2025

 

 

Mark to
Market
Adjustments
in 2025

 

 

Liabilities
Settled in
2025

 

 

Share Liabilities as of June 30,
2025

 

Share liabilities

 

$

 

 

$

346,997

 

 

$

129,269

 

 

$

(326,500

)

 

$

149,766

 

Activity of the share liabilities for the six months ended June 30, 2024 is as follows:

 

 

Share Liability as of December 31,
2023

 

 

New Share
Liabilities in
2024

 

 

Mark to
Market
Adjustments
in 2024

 

 

Liabilities
Settled in
2024

 

 

Share Liabilities as of June 30,
2024

 

Share liabilities

 

$

 

 

$

435,600

 

 

$

54,000

 

 

$

(183,600

)

 

$

306,000

 

 

Common Stock Warrants

In May 2025, a warrant to purchase 1,294,778 shares of common stock was exercised and the Company received gross proceeds of $4,915,312. As of June 30, 2025 and December 31, 2024, there were warrants to purchase shares of common stock outstanding of 221,519 and 1,516,297 shares, respectively.